Fanburg J C, Meis-Kindblom J M, Rosenberg A E
Department of Pathology, Massachusetts General Hospital, Boston 02114, USA.
Am J Surg Pathol. 1995 Sep;19(9):1029-38. doi: 10.1097/00000478-199509000-00006.
Maffucci's syndrome is classically defined as the association of multiple enchondromas and hemangiomas. Spindle-cell hemangioendothelioma (SCH), a recently described vascular tumor of purported low malignant potential, has both cavernous hemangioma and Kaposi-like features. We report six patients with Maffucci's syndrome in whom all vascular lesions were SCH. The enchondromas involved the small and long tubular bones of the extremities in all of these patients; flat bones were also involved in three patients. The SCH usually arose in the extremities, distal to the knees and elbows. Five of the six patients had multiple and separate nodules of SCH, and in four patients there was recurrent or persistent SCH within 6 months to 4 years after initial removal. One patient also had a vascular tumor in the spleen mainly with features of a low-grade angiosarcoma with separate SCH-like foci. None of the SCH have metastasized within a follow-up period averaging 20 years. Five patients are alive 14 to 31 years after presentation. One patient died from metastatic dedifferentiated chondrosarcoma. The patient with the low-grade splenic angiosarcoma is alive approximately 2 years after diagnosis. Reappraisal of the older literature suggests that some of the vascular tumors occurring in Maffucci's syndrome, previously diagnosed as hemangiomas, may in fact be SCH. The apparent association between Maffucci's syndrome and SCH, the presence of SCH in other congenital syndromes, and the young patient age and multicentric distribution of SCH unassociated with Maffucci's syndrome raise the possibility that SCH may be a manifestation of a congenital mesodermal disorder with a genetic background related to Maffucci's syndrome. Although the behavior of SCH appears to be one of a locally recurrent or persistent multicentric lesion that does not metastasize, the association of SCH-like foci in a low-grade angiosarcoma of the spleen raises the possibility that SCH may rarely be associated with a higher grade lesion. Therefore, SCH, at least in the setting of Maffucci's syndrome, should be carefully monitored.
马富西综合征传统上被定义为多发性内生软骨瘤和血管瘤并存。梭形细胞血管内皮瘤(SCH)是一种最近描述的据称恶性潜能较低的血管肿瘤,具有海绵状血管瘤和卡波西样特征。我们报告了6例马富西综合征患者,其所有血管病变均为SCH。所有这些患者的内生软骨瘤累及四肢的短管状骨和长管状骨;3例患者的扁骨也受累。SCH通常发生在四肢,位于膝部和肘部的远端。6例患者中有5例有多个独立的SCH结节,4例患者在初次切除后6个月至4年内出现SCH复发或持续存在。1例患者的脾脏还存在一个血管肿瘤,主要具有低级别血管肉瘤的特征,并伴有独立的SCH样病灶。在平均20年的随访期内,所有SCH均未发生转移。5例患者在就诊后14至31年仍存活。1例患者死于转移性去分化软骨肉瘤。诊断为低级别脾脏血管肉瘤的患者在诊断后约2年仍存活。对既往文献的重新评估表明,马富西综合征中一些以前被诊断为血管瘤的血管肿瘤实际上可能是SCH。马富西综合征与SCH之间明显的关联、其他先天性综合征中存在SCH、SCH患者年轻的年龄以及与马富西综合征无关的SCH的多中心分布,都增加了SCH可能是一种具有与马富西综合征相关的遗传背景的先天性中胚层疾病表现的可能性。尽管SCH的行为似乎是一种局部复发或持续存在的多中心病变且不发生转移,但脾脏低级别血管肉瘤中存在SCH样病灶增加了SCH可能很少与更高级别病变相关的可能性。因此,至少在马富西综合征的情况下,应仔细监测SCH。